- About
- Agenda
- Agenda
- 2022 Agenda
- Pitch Perfect
- Sponsors
- Register
- Contact Us
- MedCity Events
- MedCity Events
- INVEST
- INVEST Digital Health
- MedCity News
BeCareLink is a platform for quantifying progression in chronic neurologic disorders employing a gamified mobile app for AI-enabled neurologic assessment. Delayed detection of subtle changes in neurologic function can negatively affect patient outcomes. The BeCareLink platform delivers a remote quantitative assessment of neurologic function with Al analysis. This analysis incorporates data from a gamified mobile app and other digital biomarkers, such as a novel pulmonary device, providing HCPs and investigators a more sensitive, comprehensive neurological assessment earlier, faster, more reliably and conveniently than a standard clinical assessment. The solution has demonstrated convergent validity with traditional neurological exams in studies at Yale and Weill-Cornell. The BeCareLink app is already deployed to the general public with over 2500 MS users and is also being used in a Biogen post-marketing trial in MS. Expansion of the platform into early diagnosis and monitoring of Alzheimer’s Disease, ALS, and Myasthenia Gravis is underway.
Company HQ: Rumson, NJ
Climb’s platform puts trial operations on rails so study teams can succeed without needing a massive ops team to do so. Climb’s task-oriented dashboards keep the study unblocked and their partner ecosystem supercharges clinics large and small. Partnering with Climb helps bring novel treatments to market faster by making it easy to run clinical trials in more markets than ever before.
Corporate HQ: CA and UT
EpHealth has created a platform for Decentralized Clinical Trials that can unlock patient recruitment in primary healthcare. The platform can seamlessly integrate participants, sites and research center and has the ability to conduct full DCT trials or a hybrid one.
Company HQ: UK
HumanFirst empowers biopharma companies to unlock better research for all humans, sooner. HumanFirst is propelling the industry forward by enabling the planning, integration and analysis of wearables and sensors into clinical trials. As the experts at incorporating digital measures into clinical trials, HumanFirst has helped 22 of the 25 largest pharmaceutical companies in the world identify the right clinical measures, cross referencing proposed digital measures against thousands of past studies, and hone in on the right wearables by searching a database that is updated daily with evidence regarding 1500+ digital sensors and nearly 10,000 different measures.
Corporate HQ: San Francisco, CA
Vistim‘s high resolution cognition monitoring helps pharmaceutical companies develop treatments for neurological disorders. The lack of sensitive, objective methods to measure cognitive function in patients with neurological disorders makes clinical trials and drug development lengthy, costly, often yielding low-quality data. Vistim Labs solves this problem with CASBA: a high resolution cognition monitoring product which is used to identify and include early-disease participants, and to meaningfully power clinical trials. The CASBA artificial intelligence biomarker system uses stimulated brain activity to directly and objectively measure real-time previously-imperceivable cognitive changes, and the system is ready for use in research and validation studies.
Corporate HQ: Salt Lake City, UT